100 related articles for article (PubMed ID: 4795197)
1. [Benzbromaron in the treatment of hyperuricemia].
Charbonnet F; Rossier J
Schweiz Rundsch Med Prax; 1973 Oct; 62(44):1337-44. PubMed ID: 4795197
[No Abstract] [Full Text] [Related]
2. [Benzbromarone in the treatment of hyperuricemias].
Ravera R
Minerva Med; 1975 Mar; 66(17):783-800. PubMed ID: 1093064
[TBL] [Abstract][Full Text] [Related]
3. [Benziodarone in hyperuricemia due to renal insufficiency].
Boine L
Minerva Med; 1973 Jan; 64(4):157-9. PubMed ID: 4568713
[No Abstract] [Full Text] [Related]
4. [On clinical experiences with 2-ethyl-3(4-hydroxy-3,5-dibrombenzoyl)-benzofuran ("Benzbromaron") in the therapy of gout and hyperuricemia].
Kotzaurek R; Hueber EF
Wien Med Wochenschr; 1968 Nov; 118(47):1014-8. PubMed ID: 5704263
[No Abstract] [Full Text] [Related]
5. [Uricosuric effect of benzbromaronum on a model of pyrazine amide-induced hyperuricemia].
Kropp R
Med Klin; 1970 Aug; 65(32):1448-50. PubMed ID: 5523876
[No Abstract] [Full Text] [Related]
6. [Effect of benzbromaronum on the renal uric acid excretion in healthy persons].
Zöllner N; Dofel W; Gröbner W
Klin Wochenschr; 1970 Apr; 48(7):426-32. PubMed ID: 5521255
[No Abstract] [Full Text] [Related]
7. [Hypouricemic effect of benzbromarone especially in kidney failure].
Didier M; Olmer M
Sem Hop; 1978 Apr; 54(9-12):463-5. PubMed ID: 210519
[No Abstract] [Full Text] [Related]
8. [Combination of allopurinol and benziodarone in prolonged treatment of hyperuricemia due to chronic renal insufficiency].
Bianchi Porro G; Petrillo M; Bianchessi M
Minerva Med; 1972 Mar; 63(17):1000-9. PubMed ID: 5016057
[No Abstract] [Full Text] [Related]
9. [Hyperuricemia induced by diuretics in hypertensive patients. Curative and preventive treatment with benziodarone].
Lagrue G; Ménard J; Safar M; Schlotterer P; Oliver-Martin F; Kazandjian M; Milliez P
Therapeutique; 1971 Nov; 47(9):761-5. PubMed ID: 5147554
[No Abstract] [Full Text] [Related]
10. [Mechanism of uricosuric action of benzbromaron].
Politta G; Berthoud S; Gaudin G; Chavaz A; Fabre J
Schweiz Rundsch Med Prax; 1973 Oct; 62(44):1345-50. PubMed ID: 4753055
[No Abstract] [Full Text] [Related]
11. [Hypo-uricemic action of benzodiarone in chronic renal insufficiency].
Olmer M; Lafon J
Mars Med; 1967; 104(3):269-71. PubMed ID: 6078254
[No Abstract] [Full Text] [Related]
12. [Benziodarone in the basic treatment of gout].
Ryckewaert A; Puel M; Kuntz D
Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):33-9. PubMed ID: 5079688
[No Abstract] [Full Text] [Related]
13. [Hyperuricemia due to diuretics in hypertensive patients. Curative treatment with benziodarone].
Lagrue G; Menard J; Safar M; Schlotterer P; Milliez P
Presse Med (1893); 1971 Apr; 79(19):849-52. PubMed ID: 5576496
[No Abstract] [Full Text] [Related]
14. Allopurinol in treatment of patients with gout and chronic renal failure.
Bowie EA; Simmonds HA; North JD
N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
[No Abstract] [Full Text] [Related]
15. Hereditary nephropathy associated with hyperuricemia and gout.
Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
[TBL] [Abstract][Full Text] [Related]
16. [Prolonged allopurinol therapy in chronic renal insufficiency].
Bianchi Porro G; Bianchessi M; Tagliabue M
Arch Ital Urol Nefrol; 1968; 41(6):507-30. PubMed ID: 5736489
[No Abstract] [Full Text] [Related]
17. [Effect of benziodarone on blood levels of uric acid in terminal uremia].
Cheli O; Maffei E
Minerva Med; 1972 Jan; 63(1):10-3. PubMed ID: 5059248
[No Abstract] [Full Text] [Related]
18. [Clinical and biological effects of a new uric acid lowering substance (benziodaronum) in gout. Results of a 2-year-long study].
Barcelo P; Santamaria A
Verh Dtsch Ges Rheumatol; 1969; 1():361-70. PubMed ID: 5403652
[No Abstract] [Full Text] [Related]
19. [New, special preparations registered in Austria].
Wien Klin Wochenschr; 1973 Nov; 85(46):762-5. PubMed ID: 4751654
[No Abstract] [Full Text] [Related]
20. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
